A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

NCT05405725 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

504

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

BIOLOGICAL: ENZ215
BIOLOGICAL: Prolia

Sponsor

Enzene Biosciences Ltd.

Collaborators

[object Object]